Nicotinamide in Friedreich's ataxia: useful or not? - Wikidata - awgldk - TriplyDB

Nicotinamide in Friedreich's ataxia: useful or not?

Nicotinamide in Friedreich's ataxia: useful or not?

http://www.wikidata.org/entity/Q34846058

about

Meat Intake and the Dose of Vitamin B3 - Nicotinamide: Cause of the Causes of Disease Transitions, Health Divides, and Health Futures?Epigenetic therapy for Friedreich ataxia

P2860

Q33642585-6F5A333B-F782-4565-ABCA-831C00BCDE18 Q35180607-642BA109-E6EF-43EC-9DF1-21626442D258

P2860

Nicotinamide in Friedreich's ataxia: useful or not?

http://www.wikidata.org/entity/Q34846058

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Nicotinamide in Friedreich's ataxia: useful or not?

@ast

Nicotinamide in Friedreich's ataxia: useful or not?

@en

Nicotinamide in Friedreich's ataxia: useful or not?

@nl

type

label

Nicotinamide in Friedreich's ataxia: useful or not?

@ast

Nicotinamide in Friedreich's ataxia: useful or not?

@en

Nicotinamide in Friedreich's ataxia: useful or not?

@nl

prefLabel

Nicotinamide in Friedreich's ataxia: useful or not?

@ast

Nicotinamide in Friedreich's ataxia: useful or not?

@en

Nicotinamide in Friedreich's ataxia: useful or not?

@nl

P1433

Q34846058-8FA5F969-07A4-48C6-BCC1-6CF0088762B4

P1476

Q34846058-4530084D-CEC1-40A1-9153-5542D457E8BE

P2093

Q34846058-511DCE5B-4E25-414A-ACFC-D1B40E33CCC8

Q34846058-FFE69D90-142C-43D6-BA79-B3DA2F9316B2

P2860

Q34846058-036FA965-2171-407F-B409-457B2A388126

Q34846058-4BAEDF25-F625-4F03-8C06-7352CD729B5F

Q34846058-8F1B45A2-7769-4148-B14F-382562F59DF7

Q34846058-B22C6A1E-6A35-429F-9C0C-B6B9A82223D1

Q34846058-BA710BAC-1DF9-4160-9478-D31C697812B5

Q34846058-D78FA397-52D1-4164-AF6A-69EFBFFE56FC

P304

Q34846058-5E3EF4C2-FA01-4EB4-8687-E79F2E619591

P31

Q34846058-F5EC2056-3336-406D-969F-A05D0B55B938

P356

Q34846058-5F593F47-0B7C-47DE-8842-4F40B83C424B

P407

Q34846058-5A7A1169-9EE8-4D9B-9332-527B0674D30F

P433

Q34846058-0E7A0455-2FAF-4E2E-AA97-7B9D1410B8A3

P478

Q34846058-C63950DC-BA06-494D-9D36-EC698C9B327F

P577

Q34846058-9E5F51C5-DFE3-448A-923F-C705EB549E55

P5875

Q34846058-0D63FE56-DF66-4ECA-AAEA-D985F5DA5074

P698

Q34846058-3E8554B1-4B75-46D6-B6BB-766F21600D4A

P932

Q34846058-4F224AAE-32A9-4ED4-9ECE-24717E1E633B

P356

S0140-6736(14)60573-0

P1433

P1476

Nicotinamide in Friedreich's ataxia: useful or not?

@en

P2093

David R Lynch

http://www.w3.org/2001/XMLSchema#string

Kenneth H Fischbeck

http://www.w3.org/2001/XMLSchema#string

P2860

A rapid, noninvasive immunoassay for frataxin: utility in assessment of Friedreich ataxia

Epigenetic and neurological effects and safety of high-dose nicotinamide in patients with Friedreich's ataxia: an exploratory, open-label, dose-escalation study.

Rationale for the development of 2-aminobenzamide histone deacetylase inhibitors as therapeutics for Friedreich ataxia.

Increasing frataxin gene expression with histone deacetylase inhibitors as a therapeutic approach for Friedreich's ataxia.

Friedreich ataxia: the clinical picture.

Heterochromatinization induced by GAA-repeat hyperexpansion in Friedreich's ataxia can be reduced upon HDAC inhibition by vitamin B3.

P304

474-475

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0140-6736(14)60573-0

http://www.w3.org/2001/XMLSchema#string

P407

P433

9942

http://www.w3.org/2001/XMLSchema#string

P478

384

http://www.w3.org/2001/XMLSchema#string

P577

2014-04-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262054850

http://www.w3.org/2001/XMLSchema#string

P698

24794818

http://www.w3.org/2001/XMLSchema#string

P932

4285390

http://www.w3.org/2001/XMLSchema#string